Compare PLSE & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | STAA |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2016 | N/A |
| Metric | PLSE | STAA |
|---|---|---|
| Price | $14.45 | $23.37 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 10 |
| Target Price | $22.00 | ★ $24.56 |
| AVG Volume (30 Days) | 180.7K | ★ 1.5M |
| Earning Date | 11-05-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $86,000.00 | ★ $230,591,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,002.94 | $21.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $13.50 |
| 52 Week High | $25.00 | $30.81 |
| Indicator | PLSE | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 41.85 |
| Support Level | $14.33 | $22.90 |
| Resistance Level | $15.96 | $26.18 |
| Average True Range (ATR) | 0.71 | 1.46 |
| MACD | 0.18 | -0.11 |
| Stochastic Oscillator | 43.84 | 8.86 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.